The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the ...

Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide ...

Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesityCompleted $238.3 million initial public offering and ...

Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of tirzepatide ...